Search

Author/Creator Scholler, John

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function. Issue 12 (22nd December 2021)

Authors:
Wang, Huaishan; Chen, Hui; Liu, Shujing; Zhang, Jie; Lu, Hezhe; Somasundaram, Rajasekharan; Choi, Robin; Zhang, Gao; Ou, Lingling; Scholler, John; Tian, Shifu; Dong, Liyun; Yeye, Guo; Huang, Lili; Connelly, Thomas; Li, Ling; Huang, Alexander; Mitchell, Tara C; Fan, Yi; June, Carl H
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 12(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell. (October 2018)

Authors:
Ruella, Marco; Xu, Jun; Barrett, David; Fraietta, Joseph; Reich, Tyler; Ambrose, David; Klichinsky, Michael; Shestova, Olga; Patel, Prachi; Kulikovskaya, Irina; Nazimuddin, Farzana; Bhoj, Vijay; Orlando, Elena; Fry, Terry; Bitter, Hans; Maude, Shannon; Levine, Bruce; Nobles, Christopher; Bushman,...
Journal:
Nature medicine
Issue:
Volume 24:Number 10(2018)
Page Start:
1499
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma. (6th November 2014)

Authors:
Johnson, Laura A; Scholler, John; Ohkuri, Takayuki; Kosaka, Akemi; Patel, Prachi R; McGettigan, Shannon E; Nace, Arben; Thekkat, Pramod; Loew, Andreas; Chen, Taylor J; Fraietta, Joseph A; Posey, Avery D; Boesteanu, Alina C; Cogdill, Alexandria P; Engels, Boris; Singh, Reshma; Ezell, Tucker R; Ida...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 2(2014)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. (4th November 2015)

Authors:
Ruella, Marco; Barrett, David M; Kenderian, Saad S; Shestova, Olga; Hofmann, Ted J; Scholler, John; Lacey, Simon F; Melenhorst, Jan J; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David A; Hunter, Christopher A; Porter, David L; June, Carl H; Grupp, Stephan A; Gill, Saar
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3(2015)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells. Issue 2 (December 2015)

Authors:
Ruella, Marco; Barrett, David; Kenderian, Saad; Shestova, Olga; Hofmann, Ted; Scholler, John; Lacey, Simon; Melenhorst, Jan; Nazimuddin, Farzana; Perazzelli, Jessica; Christian, David; Hunter, Christopher; Porter, David; June, Carl; Grupp, Stephan; Gill, Saar
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 3:Issue 2(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗